See more : Equinor ASA (EQNR.OL) Income Statement Analysis – Financial Results
Complete financial analysis of Redwood Scientific Technologies, Inc. (RSCI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Redwood Scientific Technologies, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- BYD Company Limited (002594.SZ) Income Statement Analysis – Financial Results
- Bathurst Resources Limited (BTURF) Income Statement Analysis – Financial Results
- FireFly Metals Ltd (MNXMF) Income Statement Analysis – Financial Results
- Drägerwerk AG & Co. KGaA (DRW8.DE) Income Statement Analysis – Financial Results
- RHI Magnesita India Limited (RHIM.NS) Income Statement Analysis – Financial Results
Redwood Scientific Technologies, Inc. (RSCI)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.redwoodscientific.co
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.71M | 5.26M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.03M | 2.22M |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.68M | 3.04M |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 73.63% | 57.74% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 143.71K | 0.00 | 42.74K | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.48M | 143.71K | 0.00 | 42.74K | 0.00 | 0.00 | 5.37M | 3.56M |
| Other Expenses | 0.00 | 0.00 | 0.00 | -164.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.48M | 143.71K | 0.00 | 49.14K | 0.00 | 0.00 | 5.37M | 3.56M |
| Cost & Expenses | 3.48M | 143.71K | 0.00 | 49.14K | 0.00 | 0.00 | 7.40M | 5.78M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 141.67K | 21.94K |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K |
| EBITDA | -3.48M | -143.71K | 0.00 | -49.14K | 0.00 | 0.00 | 235.90K | -955.65K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.99% | -9.94% |
| Operating Income | -3.48M | -143.71K | 0.00 | -42.74K | 0.00 | 0.00 | 307.33K | -522.59K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.99% | -9.94% |
| Total Other Income/Expenses | -4.00 | 0.00 | 0.00 | -6.56K | 0.00 | 0.00 | -213.10K | -455.00K |
| Income Before Tax | -3.48M | -143.71K | 0.00 | -49.30K | 0.00 | 0.00 | 94.23K | -977.60K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.22% | -18.60% |
| Income Tax Expense | -167.90K | -228.49K | 0.00 | 6.40K | 0.00 | 0.00 | 700.00 | 36.84K |
| Net Income | -3.48M | -143.71K | 0.00 | -49.30K | 0.00 | 0.00 | 93.53K | -1.01M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.21% | -19.30% |
| EPS | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.55 | -6.02 |
| EPS Diluted | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.55 | -6.02 |
| Weighted Avg Shares Out | 193.43M | 177.93M | 177.93M | 177.93M | 0.00 | 0.00 | 168.63K | 168.63K |
| Weighted Avg Shares Out (Dil) | 193.43M | 177.93M | 177.93M | 177.93M | 0.00 | 0.00 | 168.63K | 168.63K |
Redwood Scientific Technologies Inc. Announces Finalization of TBX VAPE FREE Product Flavors
NEW YORK , May 23, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) is excited to announce the finalization of the first five flavors of its innovative TBX VAPE FREE strips. This product marks a significant milestone as the company...
Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities
NEW YORK , April 18, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities. The New York-based firm will only focus on enhancing...
Company Initiates Plans to Build Oral Thin Film Manufacturing in the USA for Its Stop Smoking and Stop Vaping Products
NEW YORK , March 14, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) is excited to announce significant milestones achieved in the year ending 2023 and its strategic plans moving forward. The company has conveyed to the Board its confidence...
Redwood Scientific Enters into Agreement with Jeeva Clinical Trials to Launch Clinical Effectiveness Study of its TBX-Free Oral Strips for Smoking and E-cigarette Cessation
Company Has Engaged George Mason University to Conduct Efficacy Study on its New Product NEW YORK , Feb. 6, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI), ("Redwood" or "the Company"), a pioneering pharmaceutical company headquartered in New York,...
Redwood Scientific Technologies Inc. (RSCI.OTC.PK) Announces Successful S1 Registration Filing and Provides Updates on TBX FREE Clinical Trial Progress
NEW YORK , Sept. 18, 2023 /PRNewswire/ -- Redwood Scientific Technologies is delighted to announce the successful filing of its S1 registration statement with the Securities and Exchange Commission (SEC).
Source: https://incomestatements.info
Category: Stock Reports